These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 33918947)

  • 1. Dual Roles of Microglia in the Basal Ganglia in Parkinson's Disease.
    Choudhury ME; Kigami Y; Tanaka J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.
    Aono H; Choudhury ME; Higaki H; Miyanishi K; Kigami Y; Fujita K; Akiyama JI; Takahashi H; Yano H; Kubo M; Nishikawa N; Nomoto M; Tanaka J
    Glia; 2017 Nov; 65(11):1833-1847. PubMed ID: 28836295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional changes of the basal ganglia circuitry in Parkinson's disease.
    Blandini F; Nappi G; Tassorelli C; Martignoni E
    Prog Neurobiol; 2000 Sep; 62(1):63-88. PubMed ID: 10821982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic and cellular plasticity in Parkinson's disease.
    Chu HY
    Acta Pharmacol Sin; 2020 Apr; 41(4):447-452. PubMed ID: 32112041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomy of the dopamine system in the basal ganglia.
    Smith Y; Kieval JZ
    Trends Neurosci; 2000 Oct; 23(10 Suppl):S28-33. PubMed ID: 11052217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantia nigra control of basal ganglia nuclei.
    Guatteo E; Cucchiaroni ML; Mercuri NB
    J Neural Transm Suppl; 2009; (73):91-101. PubMed ID: 20411770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HCN channels in the functions of basal ganglia and Parkinson's disease.
    Qi ZX; Yan Q; Fan XJ; Peng JY; Zhu HX; Jiang YM; Chen L; Zhuang QX
    Cell Mol Life Sci; 2024 Mar; 81(1):135. PubMed ID: 38478096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Milosevic L; Gramer R; Kim TH; Algarni M; Fasano A; Kalia SK; Hodaie M; Lozano AM; Popovic MR; Hutchison WD
    Neurobiol Dis; 2019 Apr; 124():46-56. PubMed ID: 30391540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.
    Kosta P; Argyropoulou MI; Markoula S; Konitsiotis S
    J Neurol; 2006 Jan; 253(1):26-32. PubMed ID: 15981079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate and Parkinson's disease.
    Blandini F; Porter RH; Greenamyre JT
    Mol Neurobiol; 1996 Feb; 12(1):73-94. PubMed ID: 8732541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.
    Miguelez C; Morera-Herreras T; Torrecilla M; Ruiz-Ortega JA; Ugedo L
    Front Neural Circuits; 2014; 8():21. PubMed ID: 24672433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation.
    Betarbet R; Porter RH; Greenamyre JT
    J Neurochem; 2000 Mar; 74(3):1166-74. PubMed ID: 10693949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
    Teismann P; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain.
    Wüllner U; Standaert DG; Testa CM; Penney JB; Young AB
    Brain Res; 1997 Sep; 768(1-2):215-23. PubMed ID: 9369318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrastriatal dopaminergic circuits of the Basal Ganglia.
    Rommelfanger KS; Wichmann T
    Front Neuroanat; 2010; 4():139. PubMed ID: 21103009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion.
    Porter RH; Greene JG; Higgins DS; Greenamyre JT
    J Neurosci; 1994 Nov; 14(11 Pt 2):7192-9. PubMed ID: 7965108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in research on basal ganglia. Introduction].
    Takada M
    Brain Nerve; 2009 Apr; 61(4):338-9. PubMed ID: 19378802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.